Cutaneous T-Cell Lymphoma (CTCL) Completed Phase 2 Trials for Bexarotene (DB00307)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00178841Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLTreatment